David Warnock is a Nephrology physician affiliated with University of Alabama at Birmingham. OpenAlex indexes 124 publications with 11,486 citations (h-index 54); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Nephrology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
619 19th Street South
Birmingham, AL 35233
Telephone
205-934-6600Registry record last updated 13 Jul 2011.
Clinical trials
- The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study
Sponsor: University of Alabama at Birmingham
- Antiproteinuric Agents and Fabry Disease
Sponsor: University of Alabama at Birmingham
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Chiesi USA, Inc.Program year20253 payments
- Chiesi USA, Inc.Program year20244 payments$13,807openpaymentsdata.cms.gov ↗
- IDORSIA PHARMACEUTICALS US INCProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
5 NIH research awards on record, funded 1988–2000 per NIH RePORTER. The latest:
- ACTIVATED SODIUM CHANNELS IN HYPERTENSION
University of Alabama at Birmingham
FY2000$277,175R01DK053161 - NA+ REABSORPTION AND H+ ION SECRETION RENAL MECHANISMS
University of Alabama at Birmingham
FY1999R01DK019407
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium
American Journal of Kidney Diseases
2018 - Global Cardiovascular and Renal Outcomes of Reduced GFR
UCL Discovery (University College London)
2017 - The global burden of chronic kidney disease: estimates, variability and pitfalls
Nature Reviews Nephrology
2016 - Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data
The Lancet Diabetes & Endocrinology
2015 - A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury
American Journal of Kidney Diseases
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Vera Bittner
University of Alabama at Birmingham
Richard Whitley, MD
University of Alabama at Birmingham
David Standaert, MD, PhD
University of Alabama at Birmingham
Erik Roberson
University of Alabama at Birmingham
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”